search again

Nationwide rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $645,654 · 10th–90th $389,045–$1,380,3840%50%10th90th$645,654Professionalmedian $380,189 · 10th–90th $1–$977,2370%20%10th90th$380,189$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$676,082.98 / $1,905,460.72 / $5,370,317.96
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$446,683.59 / $446,683.59 / $562,341.33

See more rates by state

Want provider-level rates data? We offer custom data extracts for a reasonable fee. To learn more, please email us.